Search Results for: Corms in growth
melanoma, hepatocarcinoma, osteosarcoma, ovary, and cervix tumor cells was not affected [ , , , ]. in vivo, intratumoral treatment with antibodies against mcam in melanoma, hepatocarcinoma, osteosarcoma, leiomyosarcoma, and pancreatic tumors reduced tumor growth and the formation of metastases in melanoma
invasion of the tumor and endothelial cells (antiangiogenic effect) [ , ]. our recent in vivo study demonstrated the antitumor and antivascular effects of intratumoral get with plasmid dna-encoding shrna against mcam in melanoma b f , which resulted in significant tumor growth delay and % of tumor cures...
https://www.mdpi.com/2076-393X/8/1/135/htm